Neurodegeneration drugs
These companies develop drugs to treat Alzheimer's, Parkinson's, Huntington's, ALS and other forms of dementia.
+42.4%
over 1 year · S&P 500 +11.6%
Key indicators
Health
46 / 100
Fragile
Solid
Price
P/E 49
Cheap
Expensive
Up over 1 year
8 of 17
Wallets over 90 days
1 / 2 buys / sells
Buys
Sells
Health and price: against the other tags.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
The 18 companies
LLY
+42.7%
Size: weight in the tag. Color: move over the period.
See all companies
See all companies
L
Eli Lilly
LLY
96.2%
+42.7%
B
Biogen
BIIB
2.6%
+56.9%
P
PTC Therapeutics
PTCT
0.4%
−15.3%
A
ACADIA Pharmaceuticals
ACAD
0.2%
−22.3%
D
Denali Therapeutics
DNLI
0.2%
+7.0%
B
Biohaven
BHVN
0.2%
+73.8%
K
Korsana Biosciences
KRSA
0.1%
+218.4%
D
Design Therapeutics
DSGN
<0.1%
+37.6%
A
Alector
ALEC
<0.1%
+89.6%
G
Greenland Mines
GRML
<0.1%
−86.0%
A
Acumen Pharmaceuticals
ABOS
<0.1%
−89.0%
A
Alzamend Neuro
ALZN
<0.1%
−47.0%
A
AC Immune
ACIU
−35.1%
A
Alpha Cognition
ACOG
+35.6%
A
Addex Therapeutics
ADXN
−53.9%
A
Aspen Neuroscience
ASPE
P
Prothena
PRTA
−24.8%
Q
uniQure
QURE
−20.9%